#1 of 3
71/100v3.0 six-pillar rubric
Starting at $125/mo. PeterMD is one of the providers covered in our editorial directory that dispenses or coordinates Cerebrolysin.
Read review →Cognitive · Neuropeptide Cocktail
Cerebrolysin
Cerebrolysin is a porcine brain-derived neuropeptide preparation containing low-molecular-weight peptides and free amino acids. Used in over 50 countries for stroke recovery, traumatic brain injury, and dementia.
Cerebrolysin at a glance
Cerebrolysin is a porcine brain-derived neuropeptide preparation containing low-molecular-weight peptides and free amino acids. Used in over 50 countries for stroke recovery, traumatic brain injury, and dementia. Mechanism: Neuropeptide preparation. Typical route: Intramuscular / slow IV. FDA status: Not FDA-approved in the United States. Approved and widely used in Europe, Russia, China, and parts of Asia and Latin America. Imported and dispensed through compounding pharmacies in some U.S. peptid
Drug classNeuropeptide preparation
Half-lifeVaries (cocktail)
RouteIntramuscular / slow IV
Common dosing5-30 mL/day, 10-30 day cycle
FDA statusNot approved (US)
EU/Asia approvalYes, multiple indications
Mechanism of action
Cerebrolysin's components mimic the action of endogenous neurotrophic factors, supporting neuronal survival, axonal growth, synaptic plasticity, and modulation of neuroinflammation. The exact molecular mechanism is multifactorial and incompletely characterized.
Dosing reference
Intramuscular or slow intravenous: 5-30 mL daily for 10-30 days as a treatment cycle, then off. Specific dosing depends on the indication (acute stroke uses higher doses; cognitive support uses lower doses).
Dosing information is provided for educational reference and is not medical advice. Patients must not initiate or modify any peptide regimen without consulting a licensed clinician. See our medical disclaimer.
FDA status & regulatory framework
Not FDA-approved in the United States. Approved and widely used in Europe, Russia, China, and parts of Asia and Latin America. Imported and dispensed through compounding pharmacies in some U.S. peptide-therapy practices.
U.S. telehealth providers that work with Cerebrolysin
#2 of 3
85/100v3.0 six-pillar rubric
Starting at $180/mo. Marek Health is one of the providers covered in our editorial directory that dispenses or coordinates Cerebrolysin.
Read review →#3 of 3
88/100v3.0 six-pillar rubric
Starting at $160/mo. Defy Medical is one of the providers covered in our editorial directory that dispenses or coordinates Cerebrolysin.
Read review →Related cognitive enhancement peptides
Frequently asked questions about Cerebrolysin
Is Cerebrolysin available in the United States?
Cerebrolysin is not FDA-approved. Some U.S. compounding pharmacies and integrative-medicine practices import or prepare similar formulations for off-label use.
What is the evidence base for Cerebrolysin?
Multiple randomized controlled trials, primarily conducted outside the U.S., support efficacy in acute stroke, traumatic brain injury, and vascular dementia. Cochrane reviews have noted methodological heterogeneity.